Loading...
Loading...
SRDX| Name | Value |
|---|---|
| Revenues | 28.0M |
| Cost of Revenue | 16.7M |
| Gross Profit | 11.2M |
| Operating Expense | 13.7M |
| Operating I/L | -2.5M |
| Other Income/Expense | -0.3M |
| Interest Income | 0.5M |
| Pretax | -2.8M |
| Income Tax Expense | -9.5M |
| Net Income/Loss | 6.7M |
Surmodics, Inc. provides surface modification technologies for intravascular medical devices and chemical components for in vitro diagnostic immunoassay tests and microarrays. The company operates in two segments: Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment offers surface modification coating technologies to enhance medical device performance and drug-delivery coating technologies for site-specific drug delivery. The IVD segment designs and manufactures component products for diagnostic immunoassay and molecular test applications, including protein stabilization reagents, substrates, surface coatings, and antigens.
